CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 57 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | -99.8% | 337 | -99.7% | 0.00% | – |
| Q2 2019 | $442,000 | -41.4% | 118,636 | -36.9% | 0.00% | – |
| Q1 2019 | $754,000 | -1.0% | 188,050 | -9.5% | 0.00% | -100.0% |
| Q4 2018 | $762,000 | -19.7% | 207,782 | +87.7% | 0.00% | – |
| Q3 2018 | $949,000 | +41.6% | 110,725 | +81.3% | 0.00% | – |
| Q2 2018 | $670,000 | -49.7% | 61,065 | -47.2% | 0.00% | -100.0% |
| Q1 2018 | $1,331,000 | +579.1% | 115,568 | +506.4% | 0.00% | – |
| Q4 2017 | $196,000 | +42.0% | 19,058 | +118.1% | 0.00% | – |
| Q3 2017 | $138,000 | +16.0% | 8,738 | -11.6% | 0.00% | – |
| Q2 2017 | $119,000 | -56.1% | 9,887 | -24.6% | 0.00% | – |
| Q1 2017 | $271,000 | +903.7% | 13,120 | +558.6% | 0.00% | – |
| Q4 2016 | $27,000 | +200.0% | 1,992 | +263.5% | 0.00% | – |
| Q3 2016 | $9,000 | -81.6% | 548 | -84.2% | 0.00% | – |
| Q2 2016 | $49,000 | – | 3,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
| Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
| CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
| Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
| Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
| Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
| BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
| VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |